Latest News

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

It's been a mediocre week for Revenio Group Oyj ( HEL:REG1V ) shareholders, with the stock dropping 19% to €12.90 in...

Evrofarma SA ( ATH:EVROF ) is about to trade ex-dividend in the next three days. The ex-dividend date is two business...

While NHN Corporation ( KRX:181710 ) might not have the largest market cap around , it received a lot of attention from...

Readers hoping to buy Alexandria Group Oyj ( HEL:ALEX ) for its dividend will need to make their move shortly, as the...

It looks like Wärtsilä Oyj Abp ( HEL:WRT1V ) is about to go ex-dividend in the next 3 days. The ex-dividend date is two...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Bitdeer Technologies Group acquired about 200 acres of greenfield land in Milam County, Texas for roughly US$100 million in cash, adding control over a site with access to up to 742 MW of planned power capacity for AI and high performance computing build out. The purchase consolidates Bitdeer Technologies Group’s footprint near its Rockdale facility, which can ease future site planning, power contracting, and long term infrastructure development for AI and high performance computing...

Sandvik reported that long-serving executive Nadine Crauwels, President of the Machining business area since 2020, has decided to leave after more than two decades with the group. She will remain in her role until a successor is appointed and will support the handover in an advisory capacity. The decision overlaps with a new five year strategic period for Sandvik. As a result, the timing and continuity of leadership in Machining become central questions for execution risk, capital allocation...

In September 2026, uniQure submitted a Biologics License Application to the FDA for accelerated approval of ifezuntirgene inilparvovec (AMT-130) in Huntington’s disease, alongside a Marketing Authorisation Application to the UK regulator, supported by three year Phase I/II data and multiple FDA designations. The move pushes uniQure closer to potential commercialization of a one time gene therapy in an area with no disease modifying treatments. It raises practical questions around...

Sphere Entertainment Co. recently announced that The Wizard of Oz at Sphere will add new 4D effects including animatronic Winged Monkeys, themed scents, “Glinda Glitter,” pyrotechnic fireworks, and scented apples, building on the immersive show that has run with multiple daily performances since August 2025. The expanded sensory features, developed with Warner Bros. Discovery, Google and Magnopus, signal ongoing content investment aimed at deepening guest engagement and reinforcing Sphere...

War in the Middle East, oil near $105 and central banks still lifting rates have turned the cost of money into the main story in markets. Higher-for-longer yields can hurt many assets, yet they can also reshape the earning power of selected banks and insurers. This article walks through three stocks from our rates-focused screener that look most exposed to this backdrop so you can judge whether they deserve a closer look or a wider berth. The three stocks highlighted next are only a starting...

Genmab (CPSE:GMAB) has caught investor attention after a recent swing that left the share price at DKK 2,083. The move comes against a mixed backdrop of short term declines and longer term gains. Recent trading tells a mixed story. The share price has slipped over the past week but still shows a 30 day share price return of 4.52% and a 90 day share price gain of 28.66%. The 1 year total shareholder return of 14.36% contrasts with weaker 3 and 5 year total shareholder returns, hinting at...

High dividend stocks are back under the spotlight as 10-year Treasury yields hover near 4.85% and bond investors push up the hurdle rate for every future cash flow you might own. Cash-generative value stocks suddenly feel a lot more interesting when bond markets are questioning long term debt sustainability. This article unpacks 3 high dividend, defensive stocks from our screener that appear especially exposed to this rate driven story, potentially in a way that could be favorable for...

Ichigo (TSE:2337) has released operating figures for its clean energy arm, reporting August 2026 power generation of 20,747,809 kWh, compared with 23,339,143 kWh in August 2025. Ichigo's share price has moved to ¥401.0, with a 1 day share price return of 2.04% and a 7 day share price return of 1.78%. However, momentum has faded over 90 days, during which the share price return declined 9.07%, while the 3 year total shareholder return of 36.10% still reflects a stronger longer term...

Saab (OM:SAAB B) just landed a SEK 2,900 million contract from the Swedish Defence Material Administration for continued future fighter system concept work, sharpening attention on its role in advanced defense technology. Saab shares trade at SEK577.7 after a choppy spell, with a 30 day share price return down 12% and a 7 day move also weaker. Yet the 90 day share price return of 11% and one year total shareholder return of 9% suggest longer term momentum has been firmer as fresh defence...

Vattenfall Eldistribution’s approval to build two 170 kV power lines to SSAB (OM:SSAB A) in Luleå gives the steelmaker clearer electricity access for its planned shift toward electric steel production and related decarbonization efforts. SSAB’s recent news on securing future grid capacity lands after a strong run for investors, with the share price up 37.77% year to date and a 1-year total shareholder return of 91.10%, while shorter term share price momentum has cooled slightly over the past...

Incyte reported that MINJUVI, a CD19-targeted monoclonal antibody for relapsed or refractory follicular lymphoma, is now funded in Ontario via the FAST Program, giving eligible patients earlier access while reimbursement reviews continue. This provincial funding decision signals real world traction for MINJUVI in a key Canadian market and may influence how investors view Incyte's efforts to broaden its oncology portfolio beyond Jakafi. We will now look at how Ontario funding support for...

Higher-for-longer interest rates combined with easing lending standards have turned attention to Enova International (ENVA), as the consumer lender expands through acquisitions and leans on advanced analytics and AI across its platform. Enova International’s recent pullback, with the share price down 13.25% over the past 30 days and 4.34% over the last week, comes after a strong run that includes a 17.82% 90 day share price return and a 1 year total shareholder return of 89.87%. This suggests...

Regency Centers (REG) is back in focus after EVgo and the retail REIT agreed to expand their fast charging partnership, with plans to add more than 400 stalls across U.S. shopping centers. For context, Regency Centers shares trade at US$75.31, with short term share price returns over the past quarter drifting lower. However, the year to date share price return of 10.82% and a 3 year total shareholder return of 32.45% point to more durable momentum. Scan for other retail REITs that pair...

Wholesale inflation is running hotter, energy prices are elevated and rate expectations feel more fragile ahead of the next Fed meeting. That mix can punish some sectors while rewarding others, and investors who wait for perfect clarity often end up watching from the sidelines. This article walks through three energy producers exposed to the latest inflation and oil shock, explaining how the news might help or hurt each stock. The stocks covered below are just a starting sample, and the full...

Cronos Group recently broadened its SOURZ by Spinach lineup with a Blue Raspberry Lemonade Fully Blasted 10-pack edible featuring its first 100% live resin gummy, and added Strawberry Banana and Sweet Citrus Punch vape cartridges in Ontario. The focus on live resin gummies and differentiated vape cannabinoid combinations highlights Cronos Group’s push further into higher margin, branded product categories where consumer flavor preferences drive demand. We will now look at how Cronos Group’s...